Celltrion
068270.KS
#771
Rank
NZ$51.90 B
Marketcap
NZ$237.28
Share price
1.48%
Change (1 day)
14.50%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

ESG Reports

Thumbnail Celltrion
 ESG Report 2024-2025

ESG Report 2024-2025

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2023-2024

ESG Report 2023-2024

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2022-2023

ESG Report 2022-2023

Language: English

View ESG Report